24 active trials 11 recruiting 13 Phase 3 15 disease areas
| Phase 1 | 3 | |
| Phase 1/2 | 3 | |
| Phase 2 | 5 | |
| Phase 3 | 13 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07742215 | A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients… | Myeloma Multiple | Recruiting | 2026-08-03 |
| NCT07321093 | A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting… | Relapsing-remitting Multiple Sclerosis (RRMS) | Recruiting | 2026-01-06 |
| NCT06700096 | An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single… | Hemophilia B | Recruiting | 2025-11-18 |
| NCT07119372 | Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in… | Anemia | Active, Not Recruiting | 2026-09-01 |
| NCT05726630 | Clinical Study of Divozilimab in Patients With Systemic Scleroderma | Systemic Scleroderma | Active, Not Recruiting | 2026-06-10 |
| NCT06640517 | Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in… | Plaque Psoriasis | Active, Not Recruiting | 2026-05-27 |
| NCT05802225 | Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy… | Breast Cancer | Active, Not Recruiting | 2025-07-20 |
| NCT05751928 | A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With… | Melanoma Stage III | Active, Not Recruiting | 2025-07-08 |
| NCT06640530 | Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in… | Advanced Melanoma | Active, Not Recruiting | 2025-07-08 |
| NCT05732805 | A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to… | Melanoma | Active, Not Recruiting | 2025-02-27 |
| NCT05730699 | Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum… | Neuromyelitis Optica Spectrum Disorders | Active, Not Recruiting | 2024-11-07 |
| NCT06333210 | Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in… | Axial Spondyloarthritis | Active, Not Recruiting | 2024-06-03 |
| NCT05800327 | A Two-Stage Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and… | Rheumatoid Arthritis | Active, Not Recruiting | 2023-04-05 |
| Phase 2 | ||||
| NCT07080034 | Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of… | Ulcerative Colitis (UC) | Recruiting | 2025-09-19 |
| NCT07078994 | Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and… | Crohn's Disease (CD) | Recruiting | 2025-09-17 |
| NCT07108309 | BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic… | Triple Negative Breast Cancer | Recruiting | 2025-08-07 |
| NCT06668792 | An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With… | Relapsed/Refractory Multiple Myeloma | Recruiting | 2025-02-04 |
| NCT05445076 | Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in… | Axial Spondyloarthritis | Active, Not Recruiting | 2023-04-18 |
| Phase 1/2 | ||||
| NCT06120582 | Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia… | Hemophilia B | Recruiting | 2025-06-13 |
| NCT05747261 | Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN… | Spinal Muscular Atrophy (SMA) | Recruiting | 2024-02-22 |
| NCT06185335 | A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects… | Hemophilia A | Active, Not Recruiting | 2025-04-24 |
| Phase 1 | ||||
| NCT07136389 | Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With… | Systemic Lupus Erthematosus | Recruiting | 2025-08-22 |
| NCT06715540 | Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261… | Healthy | Recruiting | 2024-12-16 |
| NCT06112808 | A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy… | Advanced Melanoma | Active, Not Recruiting | 2025-07-08 |
Melanoma (4) · Hemophilia (3) · Ankylosing Spondylitis (2) · Breast Cancer (2) · Multiple Myeloma (2) · Chronic Kidney Disease (1) · Crohn's Disease (1) · Lupus (SLE) (1) · Multiple Sclerosis (1) · Psoriasis (1)